Dr. Carpenter and Associates Reply

Abstract

Back to table of contents Previous article Next article ArticleNo AccessDr. Carpenter and Associates ReplyWILLIAM T. CARPENTER JR., DOUGLAS W. HEINRICHS, and THOMAS E. HANLONWILLIAM T. CARPENTER JR.Search for more papers by this author, DOUGLAS W. HEINRICHSSearch for more papers by this author, and THOMAS E. HANLONSearch for more papers by this authorPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.145.7.902AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail "Dr. Carpenter and Associates Reply." American Journal of Psychiatry, 145(7), p. 902 Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited ByTheories and models of negative symptoms in schizophrenia and clinical implications23 May 2022 | Nature Reviews Psychology, Vol. 1, No. 8Impaired olfactory identification and hedonic judgment in schizophrenia patients with prominent negative symptoms19 December 2019 | Cognitive Neuropsychiatry, Vol. 25, No. 2 Serum C-Reactive Protein in Patients with Deficit Schizophrenia and the Relationship with Cognitive Function 1 December 2020 | Neuropsychiatric Disease and Treatment, Vol. Volume 16Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction16 August 2019 | BMC Psychiatry, Vol. 19, No. 1The latent structure of depressive symptoms across clinical high risk and chronic phases of psychotic illness16 September 2019 | Translational Psychiatry, Vol. 9, No. 1Reduced mu opioid receptor availability in schizophrenia revealed with [11C]-carfentanil positron emission tomographic Imaging3 October 2019 | Nature Communications, Vol. 10, No. 1Harvard Review of Psychiatry, Vol. 27, No. 3The Journal of Nervous and Mental Disease, Vol. 207, No. 7Current Opinion in Psychiatry, Vol. 30, No. 3Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy study24 August 2016 | Psychopharmacology, Vol. 233, No. 21-22Avolition, Negative Symptoms, and a Clinical Science Journey and Transition to the Future31 May 2016Schizophrene Psychosen2 November 2016European Child & Adolescent Psychiatry, Vol. 25, No. 1Scientific Reports, Vol. 5, No. 1Scientific Reports, Vol. 5, No. 1Nordic Journal of Psychiatry, Vol. 69, No. 3Schizophrenia-negative symptomsMiddle East Current Psychiatry, Vol. 21, No. 1Korean Journal of Schizophrenia Research, Vol. 17, No. 1Correlation of Lifetime Symptom Dimensions with Cognitive Function and Other Clinical Characteristics in Schizophrenia PatientsKorean Journal of Schizophrenia Research, Vol. 17, No. 2Cognitive Neuropsychiatry, Vol. 18, No. 1-2Harvard Review of Psychiatry, Vol. 21, No. 1Journal of Clinical Psychopharmacology, Vol. 33, No. 4Expert Opinion on Investigational Drugs, Vol. 22, No. 7The emerging spectrum of allelic variation in schizophrenia: current evidence and strategies for the identification and functional characterization of common and rare variants1 May 2012 | Molecular Psychiatry, Vol. 18, No. 1Psychiatric Symptoms and Alcohol Use in Community Violence by Persons With a Psychotic Disorder or DepressionSuzanne Yang, M.D., Edward P. Mulvey, Ph.D., Thomas A. Loughran, Ph.D., and Barbara H. Hanusa, Ph.D.1 March 2012 | Psychiatric Services, Vol. 63, No. 3Auflösung des Schizophreniebegriffes9 March 2011 | Der Nervenarzt, Vol. 83, No. 3Middle East Current Psychiatry, Vol. 19, No. 2The Journal of Nervous and Mental Disease, Vol. 200, No. 1The Journal of Nervous and Mental Disease, Vol. 200, No. 4The Journal of Nervous and Mental Disease, Vol. 200, No. 7The Journal of Nervous and Mental Disease, Vol. 200, No. 12Journal of Korean Neuropsychiatric Association, Vol. 51, No. 5Psychopathology, Vol. 44, No. 6Expert Review of Neurotherapeutics, Vol. 11, No. 4Systematic Reviews of Categorical Versus Continuum Models in Psychosis: Evidence for Discontinuous Subpopulations Underlying a Psychometric Continuum. Implications for DSM-V, DSM-VI, and DSM-VIIAnnual Review of Clinical Psychology, Vol. 6, No. 1Evidence-Based Child Health: A Cochrane Review Journal, Vol. 5, No. 4CNS Drugs, Vol. 24, No. 1Will the Kraepelinian Dichotomy Survive DSM-V?18 March 2009 | Neuropsychopharmacology, Vol. 34, No. 9Daily Functioning and Information-Processing Skills Among Persons With SchizophreniaGinette Aubin, Ph.D.Emmanuel Stip, M.D.Isabelle Gélinas, Ph.D.Constant Rainville, Ph.D.Christine Chapparo, Ph.D.1 June 2009 | Psychiatric Services, Vol. 60, No. 6Der Nervenarzt, Vol. 80, No. 5Neuropsychopharmacology, Vol. 34, No. 6BMC Psychiatry, Vol. 9, No. 1Annals of General Psychiatry, Vol. 8, No. 1Expert Review of Neurotherapeutics, Vol. 9, No. 10Science and Recovery in SchizophreniaJeffrey A. Lieberman, M.D.Robert E. Drake, M.D., Ph.D.Lloyd I. Sederer, M.D.Aysenil Belger, Ph.D.Richard Keefe, Ph.D.Diana Perkins, M.D., M.P.H.Scott Stroup, M.D., M.P.H.1 May 2008 | Psychiatric Services, Vol. 59, No. 5Special Section on Implications of CATIE: Lessons to Take Home From CATIEWilliam T. Carpenter, M.D.Robert W. Buchanan, M.D.1 May 2008 | Psychiatric Services, Vol. 59, No. 5Nordic Journal of Psychiatry, Vol. 62, No. 5Expert Review of Neurotherapeutics, Vol. 8, No. 1The relationship between cognitive dysfunction and stress sensitivity in schizophrenia2 March 2007 | Social Psychiatry and Psychiatric Epidemiology, Vol. 42, No. 4Behavior Genetics, Vol. 37, No. 1Very poor outcome schizophrenia: Clinical and neuroimaging aspects11 July 2009 | International Review of Psychiatry, Vol. 19, No. 4Family Process, Vol. 46, No. 2Acta Psychiatrica Scandinavica, Vol. 115, No. 1Lack of association between COMT gene and deficit/nondeficit schizophrenia15 December 2006 | Behavioral and Brain Functions, Vol. 2, No. 1Subtyping schizophrenia: implications for genetic research27 June 2006 | Molecular Psychiatry, Vol. 11, No. 9Human Psychopharmacology: Clinical and Experimental, Vol. 21, No. 4Neurotoxicity Research, Vol. 10, No. 3-4Journal of Mental Health, Vol. 15, No. 2Australian & New Zealand Journal of Psychiatry, Vol. 40, No. 8Journal of Psychiatric Practice, Vol. 12, No. 6The Journal of Nervous and Mental Disease, Vol. 194, No. 9International Clinical Psychopharmacology, Vol. 21, No. 3Psychiatry: Interpersonal and Biological Processes, Vol. 69, No. 1Neural Response to Emotional Salience in Schizophrenia2 February 2005 | Neuropsychopharmacology, Vol. 30, No. 5American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 136B, No. 1Experimental Brain Research, Vol. 166, No. 1Phenomenology and the Cognitive Sciences, Vol. 4, No. 3Psychophysiology, Vol. 42, No. 4Human Psychopharmacology: Clinical and Experimental, Vol. 19, No. 8The Journal of Nervous and Mental Disease, Vol. 192, No. 7Journal of Cognitive Psychotherapy, Vol. 18, No. 3Psychiatry's Remarkable Journey: The Past 40 YearsHerbert Pardes, M.D.1 June 2003 | Psychiatric Services, Vol. 54, No. 6International Clinical Psychopharmacology, Vol. 18, No. 2International Clinical Psychopharmacology, Vol. 18, No. 6The Journal of Nervous and Mental Disease, Vol. 191, No. 9Journal of Clinical Psychology, Vol. 58, No. 7Journal of Clinical Psychopharmacology, Vol. 22, No. 6The Journal of Nervous and Mental Disease, Vol. 190, No. 8Summer Birth and Deficit Schizophrenia in Nithsdale, ScotlandThe Journal of Nervous and Mental Disease, Vol. 189, No. 9Advances in schizophreniaNature Medicine, Vol. 7, No. 6Atypical Antipsychotics: New Directions and New Challenges in the Treatment of SchizophreniaAnnual Review of Medicine, Vol. 52, No. 1Journal of Clinical Nursing, Vol. 10, No. 1The Journal of Nervous and Mental Disease, Vol. 189, No. 9The Journal of Nervous and Mental Disease, Vol. 189, No. 11Drugs, Vol. 61, No. 14Latente Hemmung und PersönlichkeitsforschungZeitschrift für Differentielle und Diagnostische Psychologie, Vol. 21, No. 4Human Psychopharmacology: Clinical and Experimental, Vol. 15, No. 2Drug Development Research, Vol. 50, No. 3-4, Vol. 1The Journal of Nervous & Mental Disease, Vol. 188, No. 2The Journal of Nervous and Mental Disease, Vol. 188, No. 3The World Journal of Biological Psychiatry, Vol. 1, No. 1Synapse, Vol. 34, No. 2Cognition & Emotion, Vol. 13, No. 5Psychiatric Rehabilitation Skills, Vol. 3, No. 1Expert Opinion on Investigational Drugs, Vol. 8, No. 4International Journal of Neuroscience, Vol. 97, No. 3-4Psychiatric genetics: search for phenotypesTrends in Neurosciences, Vol. 21, No. 3Trends in Pharmacological Sciences, Vol. 19, No. 4The Journal of Nervous &amp Mental Disease, Vol. 186, No. 4The Journal of Nervous & Mental Disease, Vol. 186, No. 8Acta Psychiatrica Scandinavica, Vol. 97, No. 2Acta Psychiatrica Scandinavica, Vol. 98, No. 1The Journal of Nervous &amp Mental Disease, Vol. 185, No. 1Psychiatry and Clinical Neurosciences, Vol. 51, No. 6Acta Psychiatrica Scandinavica, Vol. 96, No. 3European Archives of Psychiatry and Clinical Neuroscience, Vol. 246, No. 4European Archives of Psychiatry and Clinical Neuroscience, Vol. 246, No. 5, Vol. 33Acta Psychiatrica Scandinavica, Vol. 94, No. 5Acta Psychiatrica Scandinavica, Vol. 94, No. 6Nordic Journal of Psychiatry, Vol. 50, No. 6Social Psychiatry and Psychiatric Epidemiology, Vol. 30, No. 2European Archives of Psychiatry and Clinical Neuroscience, Vol. 245, No. 1Current Opinion in Psychiatry, Vol. 8, No. 1Journal of Clinical Psychopharmacology, Vol. 15, No. 5Acta Psychiatrica Scandinavica, Vol. 92, No. 3Acta Psychiatrica Scandinavica, Vol. 91, No. 3Schizophrenia: Disease Entity, Disease Entities, or Domains of PsychopathologyPsychiatric Quarterly, Vol. 65, No. 4Acta Psychiatrica Scandinavica, Vol. 89, No. 2Acta Psychiatrica Scandinavica, Vol. 89, No. 6Acta Psychiatrica Scandinavica, Vol. 89, No. s380Acta Psychiatrica Scandinavica, Vol. 89, No. s380Acta Psychiatrica Scandinavica, Vol. 89, No. s380Acta Psychiatrica Scandinavica, Vol. 89, No. s380Acta Psychiatrica Scandinavica, Vol. 90, No. s384Psychiatric Quarterly, Vol. 64, No. 4New England Journal of Medicine, Vol. 329, No. 8Psychiatry, Vol. 56, No. 2International Journal of Geriatric Psychiatry, Vol. 7, No. 3Acta Psychiatrica Scandinavica, Vol. 84, No. 6A Virus-Associated Immunopathological Theory of SchizophreniaHuman Psychopharmacology: Clinical and Experimental, Vol. 5, No. 2Human Psychopharmacology: Clinical and Experimental, Vol. 5, No. 3 Volume 145Issue 7 July 1988Pages 902-902 Metrics PDF download History Published online 1 April 2006 Published in print 1 July 1988